1 | Brief Report: Clinical Features and Outcomes of mpox in People with and Without HIV: A National Comparative Study | Coautor: López-Gatell H., Nñez I., Ceballos-Liceaga S.E., Torre A.D.L., et al. | 2024 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | WoS-id: 001279466600002 Scopus-id: 2-s2.0-85194197499
| 0 | 0 |
2 | Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data | Coautor: Lopez-Gatell, Hugo, Bello-Chavolla, Omar Yaxmehen, Antonio-Villa, Neftali Eduardo, Valdes-Ferrer, Sergio Ivan, et al. | 2023 | INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | WoS-id: 000964808800001 Scopus-id: 2-s2.0-85148912697
| 11 | 13 |
3 | Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico | Coautor: López-Gatell H., Montes-González J.A., Zaragoza-Jiménez C.A., Antonio-Villa N.E., et al. | 2023 | Frontiers In Public Health | WoS-id: 000970975300001 Scopus-id: 2-s2.0-85153448656
| 7 | 7 |
4 | Incidence of Guillain-Barre syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines | Coautor: Lopez-Gatell, Hugo, Garcia-Grimshaw, Miguel, Galnares-Olalde J.A., Bello-Chavolla O.Y., et al. | 2022 | EUROPEAN JOURNAL OF NEUROLOGY | WoS-id: 000834863000001 Scopus-id: 2-s2.0-85135274726
| 18 | 18 |
5 | Psychological and Psychiatric Events Following Immunization with Five Different Vaccines against SARS-CoV-2 | Coautor: López-Gatell H., García-Alanis M., Morales-Cárdenas M., Toapanta-Yanchapaxi L.N., et al. | 2022 | Vaccines | WoS-id: 000845141600001 Scopus-id: 2-s2.0-85137399620
| 5 | 5 |
6 | Spatiotemporal patterns of dengue and Zika incidence during the 2015-2018 outbreak of Zika in Mexico; | Coautor: Gatell-Ramírez H.L., Cortes-Escamilla A., Roche B., Rodríguez-López M.H., et al. | 2022 | SALUD PUBLICA DE MEXICO | Scopus-id: 2-s2.0-85137294566
| 0 | 6 |
7 | Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study | Coautor: Lopez-Gatell, Hugo, Garcia-Grimshaw, Miguel, Ceballos-Liceaga S.E., Hernandez-Vanegas, Laura E., et al. | 2021 | CLINICAL IMMUNOLOGY | WoS-id: 000681218600006 Scopus-id: 2-s2.0-85109046864
| 75 | 80 |
8 | Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study | Coautor: López-Gatell H., García-Grimshaw M., Ceballos-Liceaga S.E., Michel-Chávez A., et al. | 2021 | Vaccine | WoS-id: 000721246800003 Scopus-id: 2-s2.0-85118532834
| 6 | 7 |
9 | Eliminating Hepatitis C in Mexico: A Primary Health Care Approach | Coautor: López-Gatell H., De la Torre Rosas A., Kershenobich D., Svarch A.E. | 2021 | Clinical Liver Disease | Scopus-id: 2-s2.0-85118984304
| 0 | 7 |
10 | Hepatitis B seroprevalence in 10-25-year-olds in Mexico - the 2012 national health and nutrition survey (ENSANUT) results | 1ᵉʳ autor: López-Gatell H., García-García L., Echániz-Avilés G., Cruz-Hervert P., et al. | 2019 | HUMAN VACCINES & IMMUNOTHERAPEUTICS | WoS-id: 000461231000022 Scopus-id: 2-s2.0-85056176642
| 13 | 14 |
11 | Study protocol for the multicentre cohorts of Zika virus infection in pregnant women, infants, and acute clinical cases in Latin America and the Caribbean: The ZIKAlliance consortium | Coautor: López-Gatell H., Avelino-Silva V.I., Mayaud P., Gotuzzo E., et al. | 2019 | BMC INFECTIOUS DISEASES | WoS-id: 000511160500003 Scopus-id: 2-s2.0-85077245947
| 8 | 10 |
12 | Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis | 1ᵉʳ autor: López-Gatell H., García-García L., Echániz-Avilés G., Cruz-Hervert P., et al. | 2018 | Vaccine | WoS-id: 000453620100027 Scopus-id: 2-s2.0-85054733563
| 10 | 9 |